Literature DB >> 18401715

Variceal bleeding and long-acting octreotide: a new addition to the armamentarium?

George A Sanchez, Nisa Kubiliun, Jamie S Barkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18401715     DOI: 10.1007/s10620-008-0243-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

Review 1.  Gastroesophageal variceal hemorrhage.

Authors:  A I Sharara; D C Rockey
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

Review 2.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

3.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Arun J Sanyal; Norman D Grace; William D Carey
Journal:  Am J Gastroenterol       Date:  2007-09       Impact factor: 10.864

4.  Randomised trial of octreotide for long term management of cirrhosis after variceal haemorrhage.

Authors:  S A Jenkins; J N Baxter; M Critchley; A N Kingsnorth; C A Makin; S Ellenbogen; J S Grime; J G Love; R Sutton
Journal:  BMJ       Date:  1997-11-22

5.  A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.

Authors:  Laurent Spahr; Emiliano Giostra; Jean-Louis Frossard; Isabelle Morard; Gilles Mentha; Antoine Hadengue
Journal:  Am J Gastroenterol       Date:  2007-05-03       Impact factor: 10.864

6.  Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial.

Authors:  Julio D Vorobioff; Sebastián E Ferretti; Pedro Zangroniz; Marcelo Gamen; Eduardo Picabea; Fernando O Bessone; Virginia Reggiardo; Ana R Diez; Mario Tanno; Cristina Cuesta; Hugo E Tanno
Journal:  Am J Gastroenterol       Date:  2007-06-29       Impact factor: 10.864

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.